www.fdanews.com/articles/75763-sightline-technologies-raises-10-million-in-a-syndicate-led-by-ngn-capital
SIGHTLINE TECHNOLOGIES RAISES $10 MILLION IN A SYNDICATE LED BY NGN CAPITAL
August 25, 2005
NGN Capital led a U.S. $10 million financing of Sightline Technologies Ltd. ("Sightline"), an innovative medical device company located in the Advanced Technology Center in Haifa, Israel. The investment syndicate, including Vitalife, Infinity, Inventech, and the Fishman Group, purchased Series D preferred stock. Sightline is focused on commercializing and further developing the FDA-cleared ColonoSight(R) system, a colonoscope with a disposable ColonoSleeve(R) tube and sheath, which is used for diagnosing and treating abnormalities in the large intestine.